Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Abbvie Inc

Recent news which mentions Abbvie Inc

< Previous 1 2 Next >
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
Tags Abbvie Inc Breaking News: Business Merck & Co Inc
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags Biontech SE Business US: News
From CNBC.com News
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags General Mills Inc Johnson & Johnson Business
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags AstraZeneca PLC Novo Nordisk A/S Biotechnology
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Biotech and Pharmaceuticals Health & Science Business
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Amgen Inc Merck & Co Inc Abbvie Inc
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Johnson & Johnson Social issues Abbott Laboratories
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags Investment Strategy Raytheon Technologies Corp Northrop Grumman Corp
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Business News Breaking News: Business Biotechnology
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Investment strategy Abbvie Inc Merck & Co Inc
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Papa John's International Inc Advertising Nike Inc
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Zealand Pharma A/S Social issues Structure Therapeutics Inc
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Stock markets Business News Mad Money
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Lennar Corp Investment strategy KB Home
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Business News Clover Health Investments Corp Stock markets
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Universal Health Services Inc Intuitive Surgical Inc Investing
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Biotech and Pharmaceuticals Health & Science AstraZeneca PLC
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Abbvie Inc Johnson & Johnson Healthy Returns
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags UnitedHealth Group Inc CVS Health Corp Abbvie Inc
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Business News Abbvie Inc Health care industry
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Aerospace & Defense Transportation US: News
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Stock Picks Market Outlook U/S/ Markets
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Health care industry Bristol/Myers Squibb Co Biotechnology
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Health care industry Biotechnology Pharmaceuticals
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Roche Holding AG Investment Strategy AstraZeneca PLC
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Health & Science BioNTech SE Earnings
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags 5 Things to Know Politics Business News
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Business News Abbvie Inc Biotechnology
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.